Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−32.56 M USD
0.00 USD
16.24 M
About MBX Biosciences, Inc.
Sector
Industry
CEO
Peter Kent Hawryluk
Website
Headquarters
Carmel
Founded
2018
FIGI
BBG00W7W53M5
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MBX is 20.36 USD — it has increased by 0.44% in the past 24 hours. Watch MBX Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange MBX Biosciences, Inc. stocks are traded under the ticker MBX.
MBX stock has risen by 0.30% compared to the previous week, the month change is a 24.60% rise, over the last year MBX Biosciences, Inc. has showed a −11.48% decrease.
We've gathered analysts' opinions on MBX Biosciences, Inc. future price: according to them, MBX price has a max estimate of 44.00 USD and a min estimate of 30.00 USD. Watch MBX chart and read a more detailed MBX Biosciences, Inc. stock forecast: see what analysts think of MBX Biosciences, Inc. and suggest that you do with its stocks.
MBX stock is 12.65% volatile and has beta coefficient of 3.11. Track MBX Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is MBX Biosciences, Inc. there?
Today MBX Biosciences, Inc. has the market capitalization of 680.38 M, it has decreased by −12.49% over the last week.
Yes, you can track MBX Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
MBX Biosciences, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
MBX earnings for the last quarter are −2.78 USD per share, whereas the estimation was −2.72 USD resulting in a −2.33% surprise. The estimated earnings for the next quarter are −0.57 USD per share. See more details about MBX Biosciences, Inc. earnings.
MBX Biosciences, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
MBX net income for the last quarter is −18.14 M USD, while the quarter before that showed −15.86 M USD of net income which accounts for −14.41% change. Track more MBX Biosciences, Inc. financial stats to get the full picture.
No, MBX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MBX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MBX Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.